Open Access
Open access
volume 388 issue 10039 pages 86-97

Schizophrenia

Scott Donne
Akira Sawa
Poul E. Mortensen
Publication typeJournal Article
Publication date2016-07-01
scimago Q1
wos Q1
SJR12.113
CiteScore87.6
Impact factor88.5
ISSN01406736, 1474547X
General Medicine
Abstract
Schizophrenia is a complex, heterogeneous behavioural and cognitive syndrome that seems to originate from disruption of brain development caused by genetic or environmental factors, or both. Dysfunction of dopaminergic neurotransmission contributes to the genesis of psychotic symptoms, but evidence also points to a widespread and variable involvement of other brain areas and circuits. Disturbances of synaptic function might underlie abnormalities of neuronal connectivity that possibly involves interneurons, but the precise nature, location, and timing of these events are uncertain. At present, treatment mainly consists of antipsychotic drugs combined with psychological therapies, social support, and rehabilitation, but a pressing need for more effective treatments and delivery of services exists. Advances in genomics, epidemiology, and neuroscience have led to great progress in understanding the disorder, and the opportunities for further scientific breakthrough are numerous--but so are the challenges.
Found 
Found 

Top-30

Journals

10
20
30
40
50
60
70
Frontiers in Psychiatry
67 publications, 4.36%
Schizophrenia Research
57 publications, 3.71%
Translational Psychiatry
34 publications, 2.21%
Molecular Psychiatry
33 publications, 2.15%
International Journal of Molecular Sciences
32 publications, 2.08%
Journal of Psychiatric Research
32 publications, 2.08%
Psychiatry Research
32 publications, 2.08%
BMC Psychiatry
29 publications, 1.89%
Schizophrenia Bulletin
23 publications, 1.5%
Progress in Neuro-Psychopharmacology and Biological Psychiatry
21 publications, 1.37%
Cochrane Database of Systematic Reviews
20 publications, 1.3%
Scientific Reports
20 publications, 1.3%
Schizophrenia
17 publications, 1.11%
PLoS ONE
15 publications, 0.98%
Biological Psychiatry
15 publications, 0.98%
Brain Sciences
11 publications, 0.72%
Frontiers in Pharmacology
11 publications, 0.72%
Neuroscience and Biobehavioral Reviews
11 publications, 0.72%
Asian Journal of Psychiatry
11 publications, 0.72%
European Archives of Psychiatry and Clinical Neuroscience
10 publications, 0.65%
European Psychiatry
9 publications, 0.59%
Psychological Medicine
9 publications, 0.59%
Neuropsychiatric Disease and Treatment
8 publications, 0.52%
BMJ Open
8 publications, 0.52%
Cureus
8 publications, 0.52%
Cells
8 publications, 0.52%
Journal of Psychopharmacology
8 publications, 0.52%
Biomedicines
8 publications, 0.52%
Psychiatry and Clinical Neurosciences
8 publications, 0.52%
10
20
30
40
50
60
70

Publishers

50
100
150
200
250
300
350
400
450
Elsevier
403 publications, 26.22%
Springer Nature
321 publications, 20.88%
Frontiers Media S.A.
129 publications, 8.39%
MDPI
105 publications, 6.83%
Wiley
96 publications, 6.25%
Cold Spring Harbor Laboratory
71 publications, 4.62%
Taylor & Francis
51 publications, 3.32%
Oxford University Press
47 publications, 3.06%
Cambridge University Press
27 publications, 1.76%
SAGE
27 publications, 1.76%
Ovid Technologies (Wolters Kluwer Health)
24 publications, 1.56%
Public Library of Science (PLoS)
16 publications, 1.04%
BMJ
14 publications, 0.91%
Bentham Science Publishers Ltd.
10 publications, 0.65%
Institute of Electrical and Electronics Engineers (IEEE)
8 publications, 0.52%
Hindawi Limited
8 publications, 0.52%
American Chemical Society (ACS)
7 publications, 0.46%
Baishideng Publishing Group
6 publications, 0.39%
Royal Society of Chemistry (RSC)
6 publications, 0.39%
S. Karger AG
5 publications, 0.33%
Georg Thieme Verlag KG
5 publications, 0.33%
American Medical Association (AMA)
5 publications, 0.33%
Media Sphere Publishing House
5 publications, 0.33%
American Psychiatric Association Publishing
4 publications, 0.26%
Royal College of Psychiatrists
4 publications, 0.26%
Walter de Gruyter
4 publications, 0.26%
American Society for Pharmacology and Experimental Therapeutics
3 publications, 0.2%
JMIR Publications
3 publications, 0.2%
PeerJ
3 publications, 0.2%
50
100
150
200
250
300
350
400
450
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1.5k
Share
Cite this
GOST |
Cite this
GOST Copy
Donne S., Sawa A., Mortensen P. E. Schizophrenia // The Lancet. 2016. Vol. 388. No. 10039. pp. 86-97.
GOST all authors (up to 50) Copy
Donne S., Sawa A., Mortensen P. E. Schizophrenia // The Lancet. 2016. Vol. 388. No. 10039. pp. 86-97.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/S0140-6736(15)01121-6
UR - https://doi.org/10.1016/S0140-6736(15)01121-6
TI - Schizophrenia
T2 - The Lancet
AU - Donne, Scott
AU - Sawa, Akira
AU - Mortensen, Poul E.
PY - 2016
DA - 2016/07/01
PB - Elsevier
SP - 86-97
IS - 10039
VL - 388
PMID - 26777917
SN - 0140-6736
SN - 1474-547X
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2016_Donne,
author = {Scott Donne and Akira Sawa and Poul E. Mortensen},
title = {Schizophrenia},
journal = {The Lancet},
year = {2016},
volume = {388},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016/S0140-6736(15)01121-6},
number = {10039},
pages = {86--97},
doi = {10.1016/S0140-6736(15)01121-6}
}
MLA
Cite this
MLA Copy
Donne, Scott, et al. “Schizophrenia.” The Lancet, vol. 388, no. 10039, Jul. 2016, pp. 86-97. https://doi.org/10.1016/S0140-6736(15)01121-6.